Abstract
We attempted S-1 administered five days a week from March, 2004 for an 84-year-old female harboring Borrmann type 1 gastric cancer because her family did not agree to her gastrectomy. After treatment for 1 month the lesion changed into a shallow ulcer. The lesion was clinically diagnosed with CR about 3 months later. As of October, 2006, 2 years after inducing CR, we have been administering S-1 to the patient, with no regrowth of the tumor.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / pathology
-
Aged, 80 and over
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Drug Administration Schedule
-
Drug Combinations
-
Female
-
Humans
-
Oxonic Acid / therapeutic use*
-
Remission Induction
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Tegafur / therapeutic use*
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid